Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not listed in its UK prescribing information as a medicine that increases sensitivity to sunlight, and no pharmacological mechanism has been identified that would directly make your skin react differently to UV. That said, there are indirect reasons — particularly dehydration from GI side effects — why spending time in the sun while on treatment deserves a little extra thought. Mounjaro is a prescription-only medicine; whether it is right for you is assessed by a prescriber, not decided at the point of purchase.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common misconception is that Mounjaro makes your skin photosensitive in the way some antibiotics or diuretics do. It does not appear to work like that. The tirzepatide molecule acts on GIP and GLP-1 receptors involved in appetite and blood-sugar regulation; it has no known action on skin cells or melanin that would lower your UV threshold. If you look at the NHS patient information on tirzepatide, photosensitivity does not feature in the side-effect profile.
So the decision you are actually making is a different one: not whether to avoid the sun entirely, but how to manage your time outdoors sensibly while your body is adjusting to treatment. That requires understanding the indirect effects, which are real and worth knowing about.
For a fuller picture of what tirzepatide is and how it works, our tirzepatide overview covers the mechanism and licensed uses in detail.
Nausea, vomiting, diarrhoea and reduced appetite are the side effects most people encounter, especially when starting treatment or moving up a dose. Each of those effects can reduce your fluid intake or accelerate fluid loss. Add outdoor heat, sweating and sun exposure to that picture and dehydration becomes a genuine concern, not because Mounjaro changes your skin, but because it can quietly reduce how much you eat and drink on any given day.
Dehydration matters beyond thirst. In people taking medicines that affect kidney function or blood pressure, it can become a more serious issue. If you also take antihypertensives, it is worth reading about how Mounjaro interacts with blood pressure medicines before your next hot-weather outing, and raising it with your prescriber. NHS England's guidance on weight-management injections specifically flags that dehydration from GI illness during treatment can compound kidney strain.
The practical upshot: keep a water bottle to hand on warm days, especially in the first few weeks at a new dose. Little sips consistently throughout the day are easier on a sensitive stomach than a large glass all at once.
GI side effects tend to be most noticeable in the days immediately after a dose increase, then settle. If you are planning a beach holiday, a festival or anything involving extended time in the sun, it is worth thinking about where you are in your dose schedule. A long day outdoors in the heat during week one of a new dose is a harder ask than the same day three weeks later when things have quietened down.
There is no rule that says you cannot go in the sun. There is a reasonable argument for being a little more organised about it. Questions about when you inject on a given day sometimes come up in this context too, your prescriber can talk through timing with you. And if cost of treatment is on your mind while planning ahead, our page on the Eli Lilly UK price changes gives honest context on how private market pricing has shifted.
Standard sun safety (factor 30 or above, reapplying every two hours, seeking shade in the middle of the day) is good practice for anyone. On Mounjaro, those habits matter a touch more during the periods when your GI system is working hardest.
If you notice an unexpected skin reaction after sun exposure while on Mounjaro, it is always worth mentioning it. It may be entirely unrelated to treatment, but a prescriber can help you rule out other causes, including any other medicines you take that do carry photosensitivity as a known effect. Our detailed look at Mounjaro and sun sensitivity goes further on the question of whether any skin changes have been reported by users, and this page addresses the direct "does it make you burn" question specifically.
Side effects of any kind, including any unexpected skin reactions, can be reported to the MHRA through the Yellow Card scheme, a voluntary but genuinely useful reporting route that helps build the post-market safety picture for newer medicines like Mounjaro, which carries a Black Triangle (▼) status indicating it is under additional monitoring.
If you are thinking about starting treatment and want to talk through questions like this with a real clinician, our prescribers review every consultation personally. Check your eligibility and start a free consultation whenever you are ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.